ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.489,54
-0,59%
S&P 500
5.631,22
0,28%
Dow Jones
40.211,72
0,00%
Euro vs US Dollar
1,08965
-0,03%
Bitcoin
63.819,11
-1,59%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Ardelyx Inc (ARDX)

  7. Ardelyx Inc (ARDX) News

ARDX

Ardelyx (ARDX)

Ardelyx Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ARDX
DatumZeitQuelleÜberschriftSymbolFirma
18/09/202000h35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
18/09/202000h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
18/09/202000h33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
18/09/202000h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
18/09/202000h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
18/09/202000h30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
15/09/202014h00PR Newswire (US)Ardelyx Announces FDA Acceptance for Filing of its New Drug Application of Tenapanor for the Control of Serum Phosphorus in A...NASDAQ:ARDXArdelyx Inc
08/09/202014h00PR Newswire (US)Ardelyx to Participate in Three Upcoming Investor Conferences in SeptemberNASDAQ:ARDXArdelyx Inc
03/09/202023h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
06/08/202022h05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARDXArdelyx Inc
06/08/202014h05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARDXArdelyx Inc
06/08/202014h00PR Newswire (US)Ardelyx Reports Second Quarter 2020 Financial Results and Recent Business HighlightsNASDAQ:ARDXArdelyx Inc
04/08/202012h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARDXArdelyx Inc
03/08/202014h00PR Newswire (US)Ardelyx Selected as a Finalist in the Fierce Innovation Awards for the Development of its First-in-Class Product Candidate Te...NASDAQ:ARDXArdelyx Inc
24/07/202012h04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:ARDXArdelyx Inc
09/07/202012h03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ARDXArdelyx Inc
06/07/202022h47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
30/06/202014h00PR Newswire (US)Ardelyx Announces Submission of New Drug Application to the U.S. FDA for Tenapanor for the Control of Serum Phosphorus in Adu...NASDAQ:ARDXArdelyx Inc
26/06/202022h20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
25/06/202000h50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
23/06/202000h25Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ARDXArdelyx Inc
23/06/202000h25Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ARDXArdelyx Inc
18/06/202022h59Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ARDXArdelyx Inc
17/06/202022h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
17/06/202022h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
15/06/202014h00PR Newswire (US)Ardelyx Announces Positive Second Data Analysis from Ongoing NORMALIZE Phase 4 Study Evaluating Tenapanor in CKD Patients on ...NASDAQ:ARDXArdelyx Inc
12/06/202023h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
12/06/202023h40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
12/06/202023h39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
12/06/202023h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
 Showing the most relevant articles for your search:NASDAQ:ARDX

Kürzlich von Ihnen besucht

CCOM
US500
US 500
TG
TUI1
Tui
CCOM
SILVER
SILVER
DBI
DAX
DAX
COIN
ETHUSD
Ethereum
TG
LHA
Deutsche Lufthansa
NYSE
MRK
Merck
NASDAQ
AAPL
Apple
USOTC
DTEGY
Deutsche Telekom (QX)
TG
BAYN
Bayer
TG
DTE
Deutsche Telekom
NYSE
JPM
JP Morgan Chase
AMEX
XLV
Health Care Select Sector
NYSE
NKE
Nike
NASDAQ
AMZN
Amazon.com
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten